Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
25
SHWGF Quote, Financials, Valuation and Earnings
Last price:
$0.69
Seasonality move
:
-0.7%
Day range:
$0.69 - $0.69
52-week range:
$0.65 - $0.76
Dividend yield:
4.47%
P/E ratio:
11.56x
P/S ratio:
1.74x
P/B ratio:
2.07x
Volume:
--
Avg. volume:
--
1-year change:
3.67%
Market cap:
$3.1B
Revenue:
$1.8B
EPS (TTM):
$0.06
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SHWGF
Shandong Weigao Group Medical Polymer Co. Ltd.
|
-- | -- | -- | -- | -- |
|
ADAG
Adagene, Inc.
|
-- | -$0.34 | -- | -- | $9.22 |
|
CASI
CASI Pharmaceuticals, Inc.
|
-- | -- | -100% | -- | $4.00 |
|
CPHI
China Pharma Holdings, Inc.
|
-- | -- | -- | -- | -- |
|
SVA
Sinovac Biotech Ltd.
|
-- | -- | -- | -- | -- |
|
ZLAB
Zai Lab Ltd.
|
$138M | -$0.28 | 16.18% | -46.43% | $49.17 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SHWGF
Shandong Weigao Group Medical Polymer Co. Ltd.
|
$0.69 | -- | $3.1B | 11.56x | $0.01 | 4.47% | 1.74x |
|
ADAG
Adagene, Inc.
|
$1.79 | $9.22 | $84.3M | -- | $0.00 | 0% | 805.60x |
|
CASI
CASI Pharmaceuticals, Inc.
|
$0.77 | $4.00 | $15.9M | -- | $0.00 | 0% | 0.45x |
|
CPHI
China Pharma Holdings, Inc.
|
$1.24 | -- | $4M | -- | $0.00 | 0% | 1.00x |
|
SVA
Sinovac Biotech Ltd.
|
$6.47 | -- | $464.9M | -- | $55.00 | 0% | 1.50x |
|
ZLAB
Zai Lab Ltd.
|
$17.82 | $49.17 | $2B | -- | $0.00 | 0% | 4.33x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SHWGF
Shandong Weigao Group Medical Polymer Co. Ltd.
|
14.42% | -0.888 | -- | 2.59x |
|
ADAG
Adagene, Inc.
|
26.49% | 2.508 | -- | 2.23x |
|
CASI
CASI Pharmaceuticals, Inc.
|
-274.41% | 0.019 | 55.28% | 0.19x |
|
CPHI
China Pharma Holdings, Inc.
|
29.58% | -1.772 | 56.09% | 0.09x |
|
SVA
Sinovac Biotech Ltd.
|
3.46% | 7.067 | 12.91% | 11.22x |
|
ZLAB
Zai Lab Ltd.
|
22.4% | 0.005 | 5.85% | 2.56x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SHWGF
Shandong Weigao Group Medical Polymer Co. Ltd.
|
-- | -- | 7.23% | 8.41% | -- | -- |
|
ADAG
Adagene, Inc.
|
-- | -- | -42.07% | -56.44% | -- | -- |
|
CASI
CASI Pharmaceuticals, Inc.
|
$706K | -$10.2M | -405.32% | -70405.41% | -333.14% | -- |
|
CPHI
China Pharma Holdings, Inc.
|
-$257.6K | -$628.1K | -29.08% | -43.41% | -83.07% | -$277.6K |
|
SVA
Sinovac Biotech Ltd.
|
-- | -- | -1.02% | -1.05% | -- | -- |
|
ZLAB
Zai Lab Ltd.
|
$69.3M | -$48.9M | -21.74% | -26.7% | -42.05% | -$44.5M |
Shandong Weigao Group Medical Polymer Co. Ltd. vs. Competitors
-
Which has Higher Returns SHWGF or ADAG?
Adagene, Inc. has a net margin of -- compared to Shandong Weigao Group Medical Polymer Co. Ltd.'s net margin of --. Shandong Weigao Group Medical Polymer Co. Ltd.'s return on equity of 8.41% beat Adagene, Inc.'s return on equity of -56.44%.
Company Gross Margin Earnings Per Share Invested Capital SHWGFShandong Weigao Group Medical Polymer Co. Ltd.-- -- $4B ADAGAdagene, Inc.-- -- $68.7M -
What do Analysts Say About SHWGF or ADAG?
Shandong Weigao Group Medical Polymer Co. Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Adagene, Inc. has an analysts' consensus of $9.22 which suggests that it could grow by 415.32%. Given that Adagene, Inc. has higher upside potential than Shandong Weigao Group Medical Polymer Co. Ltd., analysts believe Adagene, Inc. is more attractive than Shandong Weigao Group Medical Polymer Co. Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SHWGFShandong Weigao Group Medical Polymer Co. Ltd.0 0 0 ADAGAdagene, Inc.6 2 0 -
Is SHWGF or ADAG More Risky?
Shandong Weigao Group Medical Polymer Co. Ltd. has a beta of -0.249, which suggesting that the stock is 124.868% less volatile than S&P 500. In comparison Adagene, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock SHWGF or ADAG?
Shandong Weigao Group Medical Polymer Co. Ltd. has a quarterly dividend of $0.01 per share corresponding to a yield of 4.47%. Adagene, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Shandong Weigao Group Medical Polymer Co. Ltd. pays 47.64% of its earnings as a dividend. Adagene, Inc. pays out -- of its earnings as a dividend. Shandong Weigao Group Medical Polymer Co. Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SHWGF or ADAG?
Shandong Weigao Group Medical Polymer Co. Ltd. quarterly revenues are --, which are smaller than Adagene, Inc. quarterly revenues of --. Shandong Weigao Group Medical Polymer Co. Ltd.'s net income of -- is lower than Adagene, Inc.'s net income of --. Notably, Shandong Weigao Group Medical Polymer Co. Ltd.'s price-to-earnings ratio is 11.56x while Adagene, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Shandong Weigao Group Medical Polymer Co. Ltd. is 1.74x versus 805.60x for Adagene, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SHWGFShandong Weigao Group Medical Polymer Co. Ltd.1.74x 11.56x -- -- ADAGAdagene, Inc.805.60x -- -- --
-
Which has Higher Returns SHWGF or CASI?
CASI Pharmaceuticals, Inc. has a net margin of -- compared to Shandong Weigao Group Medical Polymer Co. Ltd.'s net margin of -353.92%. Shandong Weigao Group Medical Polymer Co. Ltd.'s return on equity of 8.41% beat CASI Pharmaceuticals, Inc.'s return on equity of -70405.41%.
Company Gross Margin Earnings Per Share Invested Capital SHWGFShandong Weigao Group Medical Polymer Co. Ltd.-- -- $4B CASICASI Pharmaceuticals, Inc.22.96% -$0.68 -$6.9M -
What do Analysts Say About SHWGF or CASI?
Shandong Weigao Group Medical Polymer Co. Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand CASI Pharmaceuticals, Inc. has an analysts' consensus of $4.00 which suggests that it could grow by 417.6%. Given that CASI Pharmaceuticals, Inc. has higher upside potential than Shandong Weigao Group Medical Polymer Co. Ltd., analysts believe CASI Pharmaceuticals, Inc. is more attractive than Shandong Weigao Group Medical Polymer Co. Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SHWGFShandong Weigao Group Medical Polymer Co. Ltd.0 0 0 CASICASI Pharmaceuticals, Inc.1 0 0 -
Is SHWGF or CASI More Risky?
Shandong Weigao Group Medical Polymer Co. Ltd. has a beta of -0.249, which suggesting that the stock is 124.868% less volatile than S&P 500. In comparison CASI Pharmaceuticals, Inc. has a beta of 0.853, suggesting its less volatile than the S&P 500 by 14.657%.
-
Which is a Better Dividend Stock SHWGF or CASI?
Shandong Weigao Group Medical Polymer Co. Ltd. has a quarterly dividend of $0.01 per share corresponding to a yield of 4.47%. CASI Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Shandong Weigao Group Medical Polymer Co. Ltd. pays 47.64% of its earnings as a dividend. CASI Pharmaceuticals, Inc. pays out -- of its earnings as a dividend. Shandong Weigao Group Medical Polymer Co. Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SHWGF or CASI?
Shandong Weigao Group Medical Polymer Co. Ltd. quarterly revenues are --, which are smaller than CASI Pharmaceuticals, Inc. quarterly revenues of $3.1M. Shandong Weigao Group Medical Polymer Co. Ltd.'s net income of -- is lower than CASI Pharmaceuticals, Inc.'s net income of -$10.9M. Notably, Shandong Weigao Group Medical Polymer Co. Ltd.'s price-to-earnings ratio is 11.56x while CASI Pharmaceuticals, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Shandong Weigao Group Medical Polymer Co. Ltd. is 1.74x versus 0.45x for CASI Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SHWGFShandong Weigao Group Medical Polymer Co. Ltd.1.74x 11.56x -- -- CASICASI Pharmaceuticals, Inc.0.45x -- $3.1M -$10.9M
-
Which has Higher Returns SHWGF or CPHI?
China Pharma Holdings, Inc. has a net margin of -- compared to Shandong Weigao Group Medical Polymer Co. Ltd.'s net margin of -86.16%. Shandong Weigao Group Medical Polymer Co. Ltd.'s return on equity of 8.41% beat China Pharma Holdings, Inc.'s return on equity of -43.41%.
Company Gross Margin Earnings Per Share Invested Capital SHWGFShandong Weigao Group Medical Polymer Co. Ltd.-- -- $4B CPHIChina Pharma Holdings, Inc.-34.07% -$0.17 $12.1M -
What do Analysts Say About SHWGF or CPHI?
Shandong Weigao Group Medical Polymer Co. Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand China Pharma Holdings, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Shandong Weigao Group Medical Polymer Co. Ltd. has higher upside potential than China Pharma Holdings, Inc., analysts believe Shandong Weigao Group Medical Polymer Co. Ltd. is more attractive than China Pharma Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SHWGFShandong Weigao Group Medical Polymer Co. Ltd.0 0 0 CPHIChina Pharma Holdings, Inc.0 0 0 -
Is SHWGF or CPHI More Risky?
Shandong Weigao Group Medical Polymer Co. Ltd. has a beta of -0.249, which suggesting that the stock is 124.868% less volatile than S&P 500. In comparison China Pharma Holdings, Inc. has a beta of 1.028, suggesting its more volatile than the S&P 500 by 2.826%.
-
Which is a Better Dividend Stock SHWGF or CPHI?
Shandong Weigao Group Medical Polymer Co. Ltd. has a quarterly dividend of $0.01 per share corresponding to a yield of 4.47%. China Pharma Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Shandong Weigao Group Medical Polymer Co. Ltd. pays 47.64% of its earnings as a dividend. China Pharma Holdings, Inc. pays out -- of its earnings as a dividend. Shandong Weigao Group Medical Polymer Co. Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SHWGF or CPHI?
Shandong Weigao Group Medical Polymer Co. Ltd. quarterly revenues are --, which are smaller than China Pharma Holdings, Inc. quarterly revenues of $756.2K. Shandong Weigao Group Medical Polymer Co. Ltd.'s net income of -- is lower than China Pharma Holdings, Inc.'s net income of -$651.5K. Notably, Shandong Weigao Group Medical Polymer Co. Ltd.'s price-to-earnings ratio is 11.56x while China Pharma Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Shandong Weigao Group Medical Polymer Co. Ltd. is 1.74x versus 1.00x for China Pharma Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SHWGFShandong Weigao Group Medical Polymer Co. Ltd.1.74x 11.56x -- -- CPHIChina Pharma Holdings, Inc.1.00x -- $756.2K -$651.5K
-
Which has Higher Returns SHWGF or SVA?
Sinovac Biotech Ltd. has a net margin of -- compared to Shandong Weigao Group Medical Polymer Co. Ltd.'s net margin of --. Shandong Weigao Group Medical Polymer Co. Ltd.'s return on equity of 8.41% beat Sinovac Biotech Ltd.'s return on equity of -1.05%.
Company Gross Margin Earnings Per Share Invested Capital SHWGFShandong Weigao Group Medical Polymer Co. Ltd.-- -- $4B SVASinovac Biotech Ltd.-- -- $11.8B -
What do Analysts Say About SHWGF or SVA?
Shandong Weigao Group Medical Polymer Co. Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Sinovac Biotech Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Shandong Weigao Group Medical Polymer Co. Ltd. has higher upside potential than Sinovac Biotech Ltd., analysts believe Shandong Weigao Group Medical Polymer Co. Ltd. is more attractive than Sinovac Biotech Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SHWGFShandong Weigao Group Medical Polymer Co. Ltd.0 0 0 SVASinovac Biotech Ltd.0 0 0 -
Is SHWGF or SVA More Risky?
Shandong Weigao Group Medical Polymer Co. Ltd. has a beta of -0.249, which suggesting that the stock is 124.868% less volatile than S&P 500. In comparison Sinovac Biotech Ltd. has a beta of 0.723, suggesting its less volatile than the S&P 500 by 27.741%.
-
Which is a Better Dividend Stock SHWGF or SVA?
Shandong Weigao Group Medical Polymer Co. Ltd. has a quarterly dividend of $0.01 per share corresponding to a yield of 4.47%. Sinovac Biotech Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $55.00 per share. Shandong Weigao Group Medical Polymer Co. Ltd. pays 47.64% of its earnings as a dividend. Sinovac Biotech Ltd. pays out -328.35% of its earnings as a dividend. Shandong Weigao Group Medical Polymer Co. Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SHWGF or SVA?
Shandong Weigao Group Medical Polymer Co. Ltd. quarterly revenues are --, which are smaller than Sinovac Biotech Ltd. quarterly revenues of --. Shandong Weigao Group Medical Polymer Co. Ltd.'s net income of -- is lower than Sinovac Biotech Ltd.'s net income of --. Notably, Shandong Weigao Group Medical Polymer Co. Ltd.'s price-to-earnings ratio is 11.56x while Sinovac Biotech Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Shandong Weigao Group Medical Polymer Co. Ltd. is 1.74x versus 1.50x for Sinovac Biotech Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SHWGFShandong Weigao Group Medical Polymer Co. Ltd.1.74x 11.56x -- -- SVASinovac Biotech Ltd.1.50x -- -- --
-
Which has Higher Returns SHWGF or ZLAB?
Zai Lab Ltd. has a net margin of -- compared to Shandong Weigao Group Medical Polymer Co. Ltd.'s net margin of -30.98%. Shandong Weigao Group Medical Polymer Co. Ltd.'s return on equity of 8.41% beat Zai Lab Ltd.'s return on equity of -26.7%.
Company Gross Margin Earnings Per Share Invested Capital SHWGFShandong Weigao Group Medical Polymer Co. Ltd.-- -- $4B ZLABZai Lab Ltd.59.62% -$0.33 $979.3M -
What do Analysts Say About SHWGF or ZLAB?
Shandong Weigao Group Medical Polymer Co. Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Zai Lab Ltd. has an analysts' consensus of $49.17 which suggests that it could grow by 175.93%. Given that Zai Lab Ltd. has higher upside potential than Shandong Weigao Group Medical Polymer Co. Ltd., analysts believe Zai Lab Ltd. is more attractive than Shandong Weigao Group Medical Polymer Co. Ltd..
Company Buy Ratings Hold Ratings Sell Ratings SHWGFShandong Weigao Group Medical Polymer Co. Ltd.0 0 0 ZLABZai Lab Ltd.8 1 0 -
Is SHWGF or ZLAB More Risky?
Shandong Weigao Group Medical Polymer Co. Ltd. has a beta of -0.249, which suggesting that the stock is 124.868% less volatile than S&P 500. In comparison Zai Lab Ltd. has a beta of 0.872, suggesting its less volatile than the S&P 500 by 12.778%.
-
Which is a Better Dividend Stock SHWGF or ZLAB?
Shandong Weigao Group Medical Polymer Co. Ltd. has a quarterly dividend of $0.01 per share corresponding to a yield of 4.47%. Zai Lab Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Shandong Weigao Group Medical Polymer Co. Ltd. pays 47.64% of its earnings as a dividend. Zai Lab Ltd. pays out -- of its earnings as a dividend. Shandong Weigao Group Medical Polymer Co. Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SHWGF or ZLAB?
Shandong Weigao Group Medical Polymer Co. Ltd. quarterly revenues are --, which are smaller than Zai Lab Ltd. quarterly revenues of $116.2M. Shandong Weigao Group Medical Polymer Co. Ltd.'s net income of -- is lower than Zai Lab Ltd.'s net income of -$36M. Notably, Shandong Weigao Group Medical Polymer Co. Ltd.'s price-to-earnings ratio is 11.56x while Zai Lab Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Shandong Weigao Group Medical Polymer Co. Ltd. is 1.74x versus 4.33x for Zai Lab Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SHWGFShandong Weigao Group Medical Polymer Co. Ltd.1.74x 11.56x -- -- ZLABZai Lab Ltd.4.33x -- $116.2M -$36M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
14
SMX alert for Dec 30
SMX (Security Matters) Plc [SMX] is down 40.26% over the past day.
Buy
71
ZCSH alert for Dec 30
Grayscale Zcash Trust (ZEC) [ZCSH] is down 4.56% over the past day.
Buy
69
GDXU alert for Dec 30
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 3.19% over the past day.
